Visfatin and Omentin-1 - Markers of Nutritional Status of Newborns Born to Diabetic Mothers.

CompletedOBSERVATIONAL
Enrollment

70

Participants

Timeline

Start Date

December 13, 2019

Primary Completion Date

February 5, 2021

Study Completion Date

March 17, 2021

Conditions
Gestational DiabetesDiabetes MellitusNeonateNutritional Status
Interventions
DIAGNOSTIC_TEST

Acquisition and analysis of milk samples

"In order to ensure reproducible results, breast milk samples were collected using a breast pump. Samples were taken in the morning, after the newborn was breastfed. The entire breast was emptied. In order to ensure the stability of the microbiological and nutritional composition, the milk samples were cooled immediately after collection, and then divided into test tubes and frozen (-80 C) until the laboratory tests were made.~The concentrations of macronutrients (protein, fat, carbohydrate) in breast milk were determined using a Human Milk Analyzer (HMA; Miris, Uppsala). Tissue hormones, e.g. adipokines: visfatin, omentin-1 were determined by ELISA method using commercial reagent kits."

DIAGNOSTIC_TEST

Collection, preparation and analysis of mother's blood samples.

Blood samples were collected from the mothers (fasting if possible) on the day the milk samples were taken. After collection, fasting glucose and insulin, as well as glycated hemoglobin were marked, and the other samples were centrifuged and frozen until analyzed (-80 C). Determination of adipokines was performed by ELISA method, using commercial reagent kits.

DIAGNOSTIC_TEST

Body composition assessment

The body composition of newborns was determined by a non-invasive electrical bioimpedance method using the body composition analyzer.

OTHER

Anthropometric measurements

"Based on the mother's medical records, maternal height and pregnancy weight changes were recorded. On the day the biological material is collected, the mother was weighed.~From the baby's documentation, measurements of the length, head circumference and body weight taken after delivery and during the hospitalization were recorded. These measurements were repeated on the days of the body composition analysis."

Trial Locations (1)

50-556

Department and Clinic of Neonatology, Jan Mikulicz-Radecki University Teaching Hospital, Wroclaw Medical University, Wroclaw

All Listed Sponsors
lead

Wroclaw Medical University

OTHER

NCT04937348 - Visfatin and Omentin-1 - Markers of Nutritional Status of Newborns Born to Diabetic Mothers. | Biotech Hunter | Biotech Hunter